It's common for people to have concerns about the effectiveness of their treatment. For instance, in the context of hATTR amyloidosis treatments, some individuals may experience side effects or not see immediate improvements, which can lead to doubts about the treatment's efficacy.

Here are some points to consider
- Side read more

It's common for people to have concerns about the effectiveness of their treatment. For instance, in the context of hATTR amyloidosis treatments, some individuals may experience side effects or not see immediate improvements, which can lead to doubts about the treatment's efficacy.

Here are some points to consider:
- Side Effects: Treatments like vutrisiran can cause side effects such as diarrhea, peripheral edema, dizziness, and joint pain. These might make it seem like the treatment isn't working.
- Long-Term Data: Some treatments, like vutrisiran, are relatively new, and long-term data on their effectiveness is still being gathered. For example, the Helios-B clinical trial is set to last seven years to provide more information on the long-term safety and efficacy.
- Comparative Studies: Studies comparing treatments, such as the one involving tafamidis, show that long-term use can lead to better outcomes. Participants who took tafamidis for the entire study had better neurological function and quality-of-life scores compared to those who started with a placebo.

If you have concerns about your treatment, it's important to discuss them with your healthcare provider to weigh the risks and benefits and consider alternative options if necessary.

 This AI-generated response comes from MyAmyloidosisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

hATTR Amyloidosis Treatments: Comparing Your Options | MyAmyloidosisTeam

How To Reduce Medical Bills: Top Financial Expert Shares 10 Tips | MyAmyloidosisTeam